Wilkerson AD, Parthasarathy PB, Stabellini N, Mitchell C, et al. Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer. Clin Cancer Res 2023 Oct 26. doi: 10.1158/1078-0432.CCR-23-1349.
PMID: 37882661